[The long-term treatment card from the user's viewpoint]

C Chueca Rodríguez1, A Herrer Castejón, L Viejo Navarro

  • 1Centro de Salud Almozara, Zaragoza.

Atencion Primaria
|October 31, 1993
PubMed

Insights

The long-term treatment card (LTC) is highly favored by patients over repeat prescriptions, saving them time. However, improvements in information and medication inclusion processes are needed for better patient care.

Area of Science:

  • Health Services Research
  • Patient Experience
  • Pharmaceutical Management

Background:

  • Evaluating patient satisfaction with pharmaceutical management systems is crucial for optimizing healthcare delivery.
  • The long-term treatment card (LTC) offers an alternative to traditional repeat prescriptions, necessitating an assessment of its efficacy and user perception.

Purpose of the Study:

  • To ascertain patient opinions on the long-term treatment card (LTC) compared to repeat prescriptions.
  • To evaluate administrative time and information provision related to LTC usage.
  • To identify user criticisms and suggestions for improving the LTC system.

Main Methods:

  • A crossover study design was employed.
  • Data were collected via questionnaires administered to 397 users of the long-term treatment card at Almozara Health Centre.
  • The study focused on the Primary Care team's perspective and user feedback.

Main Results:

  • 88% of surveyed users preferred the LTC over traditional clinical prescriptions.
  • 79% reported reduced time in obtaining prescriptions with the LTC.
  • 10% experienced difficulties, primarily with collection/delivery schedules (36%), and 38% desired greater input on medication inclusion.

Conclusions:

  • The long-term treatment card (LTC) demonstrates broad patient acceptance.
  • Enhancing information dissemination regarding LTC use and function is recommended.
  • Implementing quality controls for the LTC is necessary, addressing concerns about treatment oversight and adverse effects.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...